Feasibility of a Program on a Nurse-led Telephone 6-month-follow-up for Uncontrolled Hypertensive Women

NCT ID: NCT03963934

Last Updated: 2019-10-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-12-01

Study Completion Date

2021-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluate the feasibility of a 6-month personalized support program for hypertensive and non-observant women, led by nurses by telephone follow-up.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The program includes 2 themes:

1. "Realizing my blood pressure self-measurement" according to the recommendations
2. "Optimizing my compliance": understand the antihypertensive treatment, identify the brakes and the levers when taking medication, organize the treatment taking

Visits :

1. Inclusion visit :

* Collection of consent by the nurse
* Verification of inclusion and non-inclusion criteria : measurement of compliance with a scale for each antihypertensive treatment and BP measurement
* Data collection and goal setting
* Urine collection for dosing anti-hypertension drugs
* Delivery of the schedule of telephone visits that were determined with the patient
2. Implementation of personalized support with the following steps :

* Data collection : evaluate knowledge and its potential as a patient, identify his needs
* Determination of objectives : define the objectives of the program in each theme with the patient according to the collection of data Implementation of personalized support
* 7 telephone interviews of 20 to 30 minutes use of specific teaching tools and materials by thematic assessment of achievements, validation of objectives

Evaluation of the accompaniment:

\- assessment at the final visit
3. Final visit at 6-month : Same as the inclusion visit with assessment of the support and questionnaire to assess the patient satisfaction level.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arterial Hypertension Medication Nonadherence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Prospective, monocentric, open, pilot study
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Women with uncontrolled hypertension

Women with uncontrolled hypertension and unsatisfactory medication adherence

Group Type EXPERIMENTAL

Program on a nurse-led telephone 6-month-follow-up for uncontrolled hypertensive women: a patient-tailored intervention

Intervention Type OTHER

Implementation of personalized support: The accompaniment includes 7 telephone interviews for 6 months (understanding the antihypertensive treatment, identifying the brakes and the levers when taking medication, organizing the treatment taking, making the home blood pressure)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Program on a nurse-led telephone 6-month-follow-up for uncontrolled hypertensive women: a patient-tailored intervention

Implementation of personalized support: The accompaniment includes 7 telephone interviews for 6 months (understanding the antihypertensive treatment, identifying the brakes and the levers when taking medication, organizing the treatment taking, making the home blood pressure)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Woman ≥ 18 to 79 years old,
* Hypertensive and treated with antihypertensive drug(s)
* Unsatisfactory compliance for at least one of her antihypertensive treatment with a score below 80% at the medication adherence scale
* Uncontrolled Blood Pressure (BP) : systolic BP equals to ou greater than140 and / or diastolic BP equals to ou greater than 90 mmHg at inclusion visit
* Inform consent signed
* Affiliation to a French social security scheme or beneficiary of such a scheme

Exclusion Criteria

* Patient with a history of cardio or cerebrovascular disease in the last 6 months (Stroke or Transient Ischemic Attack, myocardial infarction, heart failure)
* Patient with kidney failure requiring dialysis
* Patient with cognitive pathology: dementia, ... etc.
* Patient with type I diabetes
* Unreachable patient by phone or foreseeable inability or unwillingness to comply with study follow-up
* Patient who does not understand and does not speak French
Minimum Eligible Age

18 Years

Maximum Eligible Age

79 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Central Hospital, Nancy, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Edith DAUCHY, RN

Role: PRINCIPAL_INVESTIGATOR

CHRU Nancy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Edith DAUCHY, RN

Role: CONTACT

33 3 83 15 73 13

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019-A01921-56

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mobile Health Management of Hypertension
NCT05856955 NOT_YET_RECRUITING NA